Skip to main content
. 2023 Feb 21;10:1097466. doi: 10.3389/fmed.2023.1097466

Table 2.

Clinical and laboratory parameters among SCD patients 1 month before, during, and 1 month after Ramadan.

Item Normal range 1 month before During 1 month after p-value
Number of VOC Mean (SD) 0.21 (0.41) 0.27 (0.45) 0.23 (0.43) 0.715
Number of hemolytic crises Mean (SD) 0.08 (0.27) 0.13 (0.35) 0.13 (0.35) 0.535
Length of hospital stay (days) Mean (SD) 1.12 (2.4) 1.37 (3.52) 0.88 (1.88) 0.623
The total dose of morphine (mg) Mean (SD) 24.8 (59.0) 15.8 (55.0) 7.12 (16.96) 0.182
Use of antibiotics Yes (n, %) 6 (11.5) 7 (13.5) 10 (19.2) 0.486*
No (n, %) 46 (88.5) 45 (86.5) 42 (80.8)
The need for exchange transfusion Yes (n, %) 3 (5.8) 2 (3.8) 1 (1.9) 0.607*
No (n, %) 49 (94.2) 50 (96.2) 51 (98.1)
Admission to ICU Yes (n, %) 3 (5.8) 2 (3.8) 1 (1.9) 0.607*
No (n, %) 49 (94.2) 50 (96.2) 51 (98.1)
Number of ICU days Mean (SD) 0.13 (0.63) 0.12 (0.51) 0.00 (0.00) 0.596
WBC count × 103/μL 4–10 Mean (SD) 8.62 (3.66) 7.75 (3.03) 9.07 (4.76) 0.212
Hb (g/dL) 13–17 Mean (SD) 9.86 (1.50) 9.74 (1.91) 9.97 (1.49) 0.761
Platelet count × 103/μL 150–410 Mean (SD) 271.39 (138.92) 234.35 (104.40) 317.08 (158.90) 0.003
Reticulocytes count × 103/ μL 50–100 Mean (SD) 198.84 (76.23) 150.34 (55.58) 197.36 (77.17) < 0.001
Urea (mmol/L) 2.5–7.8 Mean (SD) 2.85 (1.31) 3.08 (0.98) 6.04 (10.95) 0.098
Creatinine (μmol/L) 62–106 Mean (SD) 65.69 (2.42) 67.90 (19.35) 60.38 (22.05) 0.038
Bilirubin (μmol/L) 0–21 Mean (SD) 33.89 (26.10) 25.27 (13.88) 31.87 (24.35) 0.063
LDH (U/L) 105–333 Mean (SD) 365.89 (150.12) 355.67 (153.83) 444.00 (136.03) NA**

SCD, Sickle cell disease; VOC, Vaso-occlusive crisis; ICU, intensive care unit; WBCs, White blood cells; Hb, Hemoglobin; LDH, Lactate dehydrogenase; NA, not available; (*), One-way with repeated measures ANOVA with a Greenhouse-Geisser correction ± Friedman tests were used; (**), unavailability of LDH values for most of the cases in the three time periods did not allow for analysis of this variable.